OKX · regulatory
OKXICE Tokenized Stock Plan Faces 26 Issuer Objections
The 26 objections narrow the stocks OKXICE can offer under the SEC exemption but do not block the joint venture from launching with other eligible securities.
Do the 26 issuer objections block OKXICE from launching?
No. They prevent the venue from offering the objecting issuers' tokenized shares under the current SEC exemption, but other eligible stocks can still proceed.
Orbitrum Investor Impact
How large is the issuer pushback?
Twenty six issuers had objected by October 26, including IBM, Oracle, Intel and IonQ. Twenty three were among the original 62 company roster, or about 37%.
Why do the objections matter for OKX?
OKXICE collects a service fee on each executed trade, so a smaller eligible stock lineup could reduce trading breadth and the transaction volume available to generate fees.
Is OKXICE already live?
Not yet. OKX still describes the venue as coming, while the SEC lists OKXICE's notice of intent dated October 4 and requires at least 30 calendar days of public notice before operations.
What happens next for OKXICE?
The venue can make a stock available only after the applicable objection period expires without a timely issuer objection. The sources checked do not specify a launch date.
Sources
- CoinDesk — Intel, Oracle, IBM join growing list of firms objecting to OKX–ICE tokenized stock plans
- OKXICE TSV — Public Notice of OKXICE TSV
- U.S. Securities and Exchange Commission — Frequently Asked Questions on the Innovation Exemption
- U.S. Securities and Exchange Commission — Innovation Exemption
- OKX — OKXICE Tokenized Securities Venue | Public Notice | OKX United States
Original signal: CoinDesk ↗
Continue researching
Projects mentioned in this Signal
Continue your research in Orbitrum. Access to full expert research depends on each expert's offer.
Explore by sector
Explore the sectors behind this story
See more Orbitrum in Google
Add Orbitrum as a Preferred Source to make our research more likely to appear for you in Google Search.